Hainan Poly Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HAINAN POLY PHARM
HAINAN POLY PHARM has five approved drugs.
There are two tentative approvals on HAINAN POLY PHARM drugs.
Drugs and US Patents for Hainan Poly Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hainan Poly Pharm | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 217314-002 | May 22, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hainan Poly Pharm | GADOBUTROL | gadobutrol | SOLUTION;INTRAVENOUS | 217480-006 | Apr 16, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hainan Poly Pharm | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 215890-001 | Aug 18, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hainan Poly Pharm | GADOBUTROL | gadobutrol | SOLUTION;INTRAVENOUS | 217480-001 | Mar 15, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hainan Poly Pharm | GADOBUTROL | gadobutrol | SOLUTION;INTRAVENOUS | 217480-003 | Apr 16, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

